MarketResearchReports.Biz
announces addition of new report"
Cervical Cancer Global Clinical Trials Review, H1, 2016 "to
its database.
GlobalData's
clinical trial report, Cervical
Cancer Global
Clinical Trials Review, H1, 2016" provides an overview of
Cervical Cancer clinical trials scenario. This report provides top
line data relating to the clinical trials on Cervical Cancer. Report
includes an overview of trial numbers and their average enrollment in
top countries conducted across the globe. The report offers coverage
of disease clinical trials by region, country (G7 & E7), phase,
trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of
ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download
Sample copy of this Report @
Scope
- The report provides a
snapshot of the global clinical trials landscape
- Report provides top level
data related to the clinical trials by Region, Country (G7 & E7),
Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top
companies involved and enlists all trials (Trial title, Phase, and
Status) pertaining to the company
- The report provides all the
unaccomplished trials (Terminated, Suspended and Withdrawn) with
reason for unaccomplishment
- The Report provides
enrollment trends for the past five years
- Report provides latest news
for the past three months
Reasons to buy
- Assists in formulating key
business strategies with regards to investment
- Helps in identifying
prominent locations for conducting clinical trials which saves time
and cost
- Provides top level analysis
of Global Clinical Trials Market which helps in identifying key
business opportunities
- Supports understanding of
trials count and enrollment trends by country in global therapeutics
market
- Aids in interpreting the
success rates of clinical trials by providing a comparative scenario
of completed and uncompleted (terminated, suspended or withdrawn)
trials
- Facilitates clinical trial
assessment of the indication on a global, regional and country level
Table
of Content :
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing
to Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Five Countries Contributing
to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing
to Clinical Trials in Central and South America 13
Clinical Trials by G7
Countries: Proportion of Cervical Cancer to Oncology Clinical Trials
14
Clinical Trials by Phase in G7
Countries 15
Clinical Trials in G7 Countries
by Trial Status 16
Clinical Trials by E7
Countries: Proportion of Cervical Cancer to Oncology Clinical Trials
17
Clinical Trials by Phase in E7
Countries 18
Clinical Trials in E7 Countries
by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status
22
Clinical Trials by End Point
Status 23
Subjects Recruited Over a
Period of Time 24
Clinical Trials by Sponsor Type
25
Prominent Sponsors 26
Latest Clinical Trials News on
Cervical Cancer 29
Apr 25, 2016: Phase II Cervical
Cancer Study with Advaxis Axalimogene Filolisbac Selected for Poster
Discussion Session at the 2016 ASCO Annual Meeting 29
Apr 18, 2016: New HPV vaccine
could curb cervical cancers and health costs if adopted widely 29
Mar 29, 2016: Inovio Updates
INO-3112 HPV Immunotherapy Development Plan 30
Mar 29, 2016: Advaxis
Combination Trial with MedImmune Completes First Dose-Escalation
Cohort 30
Mar 07, 2016: Dosing Begins in
High Dose Expansion Cohort in Phase 2 Study of Axalimogene Filolisbac
in Patients With Recurrent Cervical Cancer 31
Mar 04, 2016: Karyopharms
Selinexor First-in-Human Phase 1 Clinical Trial Data Published in
Journal of Clinical Oncology 31
Mar 02, 2016: New trial
launched to test cancer vaccine 32
Feb 11, 2016: Navidea
Biopharmaceuticals Enrolls First Patient in Cervical Cancer Study of
Lymphoseek 33
Clinical Trial Profile
Snapshots 35
Appendix 512
Abbreviations 512
Definitions 512
Research Methodology 513
Secondary Research 513
About GlobalData 514
Contact Us 514
Disclaimer 514
Source 515
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
us:
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment